EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer-Reference-Cited by-同舟云学术

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Published:2022-10 Issue: Volume:174 Page:299-309
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Oaknin Ana,Monk Bradley J.,Vergote Ignace^ORCID,Cristina de Melo Andreia^ORCID,Kim Yong-Man,Lisyanskaya Alla S.,Samouëlian Vanessa,Kim Hee Seung,Gotovkin Evgeniy A.,Damian Fernanda^ORCID,Chang Chih-Long,Takahashi Shunji,Li Jingjin,Mathias Melissa,Fury Matthew G.,Ivanescu Cristina,Reaney Matthew^ORCID,LaFontaine Patrick R.^ORCID,Lowy Israel,Harnett James,Chen Chieh-I,Tewari Krishnansu S.

Funder

Regeneron Pharmaceuticals

Sanofi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference23 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J Clin,2021

2. Cervical cancer: Statistics;American Society of Clinical Oncology,2021

3. When Pap testing fails to prevent cervix cancer: a qualitative study of the experience of screened women under 50 with advanced cervix cancer in Canada;Corkum;Cureus,2019

4. The impact of cervical cancer on quality of life--the components and means for management;Herzog;Gynecol Oncol,2007

5. Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study;Chase;Gynecol Oncol,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review;Clinical and Experimental Obstetrics & Gynecology;2024-07-11

2. Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer;New England Journal of Medicine;2024-07-04

3. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study;European Journal of Cancer;2024-05

4. Systematic Review of the Literature on Multiple Co-occurring Symptoms in Patients Receiving Treatment for Gynecologic Cancers;Seminars in Oncology Nursing;2024-02

5. The effects of adjunctive interventions on cervical skin health post-chemotherapy: a systematic review and meta-analysis;European Journal of Gynaecological Oncology;2024